These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7455991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Malondialdehyde formation in rat platelet-rich plasma. I.A kinetic approach.
    Rajtar G, Livio M, Merino J, de Gaetano G.
    Thromb Haemost; 1980 Oct 31; 44(2):49-51. PubMed ID: 7455990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB, Ingerman CM, Silver MJ.
    J Lab Clin Med; 1976 Jul 31; 88(1):167-72. PubMed ID: 932533
    [Abstract] [Full Text] [Related]

  • 5. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity.
    Cerletti C.
    Int J Tissue React; 1985 Jul 31; 7(4):309-12. PubMed ID: 3934097
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
    Busse WD, Seuter F.
    Agents Actions Suppl; 1979 Jul 31; (4):127-37. PubMed ID: 291303
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pressure-induced metabolic activation of platelets demonstrated in vitro by determination of malondialdehyde formation.
    Torsellini A, Doni L, Palinski W, Guidi G, Lombardi V.
    Thromb Haemost; 1984 Aug 31; 52(1):4-6. PubMed ID: 6238444
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet malondialdehyde in cardiovascular disease: effect of prosthetic heart valves and cardioactive drugs on production.
    Sullivan JM, Taylor JC, Samaha JK.
    Thromb Haemost; 1980 Oct 31; 44(2):76-80. PubMed ID: 7455995
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets.
    Pönicke K, Förster W.
    Biomed Biochim Acta; 1984 Oct 31; 43(8-9):S459-62. PubMed ID: 6440558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC.
    Br J Pharmacol; 1997 May 31; 121(1):105-17. PubMed ID: 9146894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.